SGSH and mucopolysaccharidosis type 3A: Taken together, these data demonstrated that the level of sulphamidase activity achieved in the brain of MPS-IIIA mice that were injected with AAVs encoding the fully modified sulphamidase is sufficient to improve behavioural abnormalities.